2012
DOI: 10.1016/j.toxicon.2012.04.336
|View full text |Cite
|
Sign up to set email alerts
|

Receptor-targeting mechanisms of pain-causing toxins: How ow?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
60
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(61 citation statements)
references
References 119 publications
0
60
0
1
Order By: Relevance
“…Duplication and hypermutability of toxin genes accelerates the neo-functionalization of protein scaffolds commonly found in animal venoms, such as those belonging to the prolific Kunitz, PLA2, and inhibitor cysteine knot families (Bohlen and Julius, 2012). The comparison of MitTx with other known Kunitz and PLA2 structures illustrates the repeated use of regions peripheral to their compact and rigid cores in specifying interactions with subunits or physiological targets.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Duplication and hypermutability of toxin genes accelerates the neo-functionalization of protein scaffolds commonly found in animal venoms, such as those belonging to the prolific Kunitz, PLA2, and inhibitor cysteine knot families (Bohlen and Julius, 2012). The comparison of MitTx with other known Kunitz and PLA2 structures illustrates the repeated use of regions peripheral to their compact and rigid cores in specifying interactions with subunits or physiological targets.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, snake (Bohlen et al, 2011; Diochot et al, 2012), spider (Escoubas et al, 2000) and sea anemone toxins (Diochot et al, 2004; Karczewski et al, 2010) have been identified that elicit or suppress pain by selectively activating or blocking ASICs (Bohlen and Julius, 2012; Chen et al, 2005; Karczewski et al, 2010). In addition to validating a role for ASICs in nociception and pain sensation, peptide toxins provide powerful tools to arrest ASICs in specific conformational states for pharmacological, biophysical, and structural studies (Baconguis and Gouaux, 2012; Baconguis et al, 2013; Bohlen et al, 2011; Chen et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Some of these probably act indirectly by stimulating pathways that can sensitise TRPV1 function (Bohlen and Julius 2012), but the toxins from tarantula spiders act directly. These cysteine-rich (inhibitor cysteine knot, ICK) toxins contain internal disulfide bonds that stabilise the structure of the toxin.…”
Section: Vanillotoxinsmentioning
confidence: 99%
“…This signature may be reduced to the more general principal structural motif CX 6 CX n CC (C 1 X 6 C 2 X 5 C 4 C 5 in our case), and extra structural motif CXCX n CXC (C 6 XC 7 X m C 8 XC 9 in our case) that are characteristic of spider neurotoxins [23]. The principal structural motif and the extra structural motif in turn conform to the more general ICK motif CX 2-7 CX 3-11 CX 0-7 CX 1-17 CX [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] …”
Section: Ottx Sequence Analysismentioning
confidence: 96%
“…For instance, Agelenopsis aperta produces an array of a-agatoxins (low-molecular-mass blockers of post-synaptic glutamate receptors), l-agatoxins (peptide activators of sodium channels) and x-agatoxins (peptide blockers of diverse calcium channels) [4]. With the recent description of compounds that affect 'unconventional' targets, such as pain receptors in humans [5,6], the pharmacological potential of spider venom seems vast but largely unexplored. Only a dozen or so species have been investigated in detail, representing a minor faction of the known biodiversity.…”
mentioning
confidence: 99%